InsidersTradesSigma
Follow the 큐리오시스 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 큐리오시스 has logged 29 reports. Market capitalisation: €133.7bn. The latest transaction was filed on 7 July 2026 (Other). Among the most active insiders: 신지훈. Every trade is openly available.
9
Insider Decl.
n/a
Thresholds
€44,126
7 ops.
Buy Volume
n/a
1 ops.
Sell Volume
24Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,347 of 29,062 companies
27.8
score / 100
Value19
Quality36
FCF yld-7.2%
Earn yld-5.9%
EV/EBITDA·
ROE-50%
Gross mgn48%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 7 July 2026
Declarations29 total
Other
Other
Other
Other
Other
Other
Other
Other
Other
Other
Other
Other
Other
Other
Other
Other
Other
Other
Other
Other
KRXDART:20260707000003
25 of 29 declarations
关于 큐리오시스
큐리오시스 是一家在XKRX市场上市的医疗保健和制药领域的公司。它专注于开发创新解决方案以提升医疗保健水平。